Ketone drink study reveals surprising effects on blood hormones
NCT ID NCT06053138
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This completed study with 16 healthy adults tested how a ketone supplement affects beta-hydroxybutyrate (BHB) levels and erythropoietin (EPO), a hormone that controls red blood cell production. Participants took either the ketone drink or a placebo for two weeks. Researchers measured BHB from different blood sampling sites and checked EPO, estradiol, and ferritin levels. The goal was to understand ketosis effects on these markers, not to treat any disease.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Ketone monoester dietary supplement
What this could lead to
If successful, this could help researchers understand how ketosis influences erythropoietin and hormone levels, potentially guiding future studies on metabolic health.
What could go wrong
This is a small, early-stage study with only 16 healthy participants, so results may not apply to broader populations or have direct clinical impact.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KETOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Department of Internal Medicine, Viborg Regional Hospital
Viborg, 8800, Denmark